메뉴 건너뛰기




Volumn 20, Issue 2, 2017, Pages 245-267

Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment

Author keywords

Anti angiogenesis; Clinical trials; Combination therapy; DNA methyltransferase inhibitors; Epi drugs; Histone deacetylase inhibitors; Solid tumors; Tumor vasculature

Indexed keywords

6 [4 (4 ETHYL 1 PIPERAZINYLMETHYL)PHENYL] 4 (ALPHA METHYLBENZYLAMINO) 7H PYRROLO[2,3 D]PYRIMIDINE; ARYLBUTYRIC ACID DERIVATIVE; AZACITIDINE; BELINOSTAT; BEVACIZUMAB; BUTYRIC ACID; CURCUMIN; DACINOSTAT; DECITABINE; DISULFIRAM; DNA METHYLTRANSFERASE INHIBITOR; ENTINOSTAT; EPIGALLOCATECHIN GALLATE; ERLOTINIB; GEFITINIB; GUADECITABINE; HISTONE DEACETYLASE INHIBITOR; HYDRALAZINE; PANOBINOSTAT; PAZOPANIB; RAPAMYCIN; RESVERATROL; ROMIDEPSIN; SILYMARIN; SIRTUIN; TRICHOSTATIN A; UNINDEXED DRUG; VALPROIC ACID; VORINOSTAT; ZEBULARINE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT;

EID: 85017101403     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-017-9551-z     Document Type: Review
Times cited : (25)

References (211)
  • 1
    • 79952384705 scopus 로고    scopus 로고
    • Cancer epigenetics reaches mainstream oncology
    • Rodríguez-Paredes M, Esteller M (2011) Cancer epigenetics reaches mainstream oncology. Nat Med 17(3):330–339
    • (2011) Nat Med , vol.17 , Issue.3 , pp. 330-339
    • Rodríguez-Paredes, M.1    Esteller, M.2
  • 4
    • 0036144048 scopus 로고    scopus 로고
    • DNA methylation patterns and epigenetic memory
    • COI: 1:CAS:528:DC%2BD38Xos1ehsQ%3D%3D
    • Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16(1):6–21
    • (2002) Genes Dev , vol.16 , Issue.1 , pp. 6-21
    • Bird, A.1
  • 5
    • 79251566746 scopus 로고    scopus 로고
    • Physical and functional HAT/HDAC interplay regulates protein acetylation balance
    • Peserico A, Simone C (2011) Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J Biomed Biotechnol. doi:10.1155/2011/371832
    • (2011) J Biomed Biotechnol
    • Peserico, A.1    Simone, C.2
  • 8
    • 84949908674 scopus 로고    scopus 로고
    • Epigenetic treatment of solid tumours: a review of clinical trials
    • Nervi C, De Marinis E, Codacci-Pisanelli G (2015) Epigenetic treatment of solid tumours: a review of clinical trials. Clin Epigenet 7(1):127
    • (2015) Clin Epigenet , vol.7 , Issue.1 , pp. 127
    • Nervi, C.1    De Marinis, E.2    Codacci-Pisanelli, G.3
  • 9
    • 0036488643 scopus 로고    scopus 로고
    • Natural products in cancer chemotherapy: past, present and future
    • COI: 1:CAS:528:DC%2BD38XitVehtL8%3D
    • Mann J (2002) Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer 2(2):143–148
    • (2002) Nat Rev Cancer , vol.2 , Issue.2 , pp. 143-148
    • Mann, J.1
  • 10
    • 84928945719 scopus 로고    scopus 로고
    • Naturally occurring products in cancer therapy
    • COI: 1:STN:280:DC%2BC2MfnvVWhsw%3D%3D
    • Rajesh E, Sankari LS, Malathi L, Krupaa JR (2015) Naturally occurring products in cancer therapy. J Pharm Bioallied Sci 7(Suppl 1):S181–S183
    • (2015) J Pharm Bioallied Sci , vol.7 , pp. S181-S183
    • Rajesh, E.1    Sankari, L.S.2    Malathi, L.3    Krupaa, J.R.4
  • 11
    • 84879095158 scopus 로고    scopus 로고
    • Perspectives on natural product epigenetic modulators in chemical biology and medicine
    • COI: 1:CAS:528:DC%2BC3sXmtVWqs7s%3D
    • Cherblanc FL, Davidson RWM, Di Fruscia P, Srimongkolpithak N, Fuchter MJ (2013) Perspectives on natural product epigenetic modulators in chemical biology and medicine. Nat Prod Rep 30(5):605
    • (2013) Nat Prod Rep , vol.30 , Issue.5 , pp. 605
    • Cherblanc, F.L.1    Davidson, R.W.M.2    Di Fruscia, P.3    Srimongkolpithak, N.4    Fuchter, M.J.5
  • 12
    • 33645987615 scopus 로고    scopus 로고
    • Epigenetic control using natural products and synthetic molecules
    • COI: 1:CAS:528:DC%2BD28Xislygsbo%3D
    • Suzuki T, Miyata N (2006) Epigenetic control using natural products and synthetic molecules. Curr Med Chem 13(8):935–958
    • (2006) Curr Med Chem , vol.13 , Issue.8 , pp. 935-958
    • Suzuki, T.1    Miyata, N.2
  • 13
    • 0345357773 scopus 로고    scopus 로고
    • Gene silencing in cancer in association with promoter hypermethylation
    • COI: 1:CAS:528:DC%2BD3sXptFKmu7s%3D
    • Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349(21):2042–2054
    • (2003) N Engl J Med , vol.349 , Issue.21 , pp. 2042-2054
    • Herman, J.G.1    Baylin, S.B.2
  • 14
    • 33947315736 scopus 로고    scopus 로고
    • Cancer epigenomics: DNA methylomes and histone-modification maps
    • COI: 1:CAS:528:DC%2BD2sXivVGktbk%3D
    • Esteller M (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8(4):286–298
    • (2007) Nat Rev Genet , vol.8 , Issue.4 , pp. 286-298
    • Esteller, M.1
  • 15
    • 0031469819 scopus 로고    scopus 로고
    • Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
    • COI: 1:CAS:528:DyaK2sXns12rsL8%3D
    • Boehm T, Folkman J, Browder T, O’Reilly MS (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390(6658):404–407
    • (1997) Nature , vol.390 , Issue.6658 , pp. 404-407
    • Boehm, T.1    Folkman, J.2    Browder, T.3    O’Reilly, M.S.4
  • 16
    • 0034090097 scopus 로고    scopus 로고
    • Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation
    • COI: 1:CAS:528:DC%2BD3cXks1SksLw%3D
    • Griffioen AW, Molema G (2000) Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52(2):237–268
    • (2000) Pharmacol Rev , vol.52 , Issue.2 , pp. 237-268
    • Griffioen, A.W.1    Molema, G.2
  • 17
    • 47949099628 scopus 로고    scopus 로고
    • Modes of resistance to anti-angiogenic therapy
    • COI: 1:CAS:528:DC%2BD1cXovV2lsrk%3D
    • Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8(8):592–603
    • (2008) Nat Rev Cancer , vol.8 , Issue.8 , pp. 592-603
    • Bergers, G.1    Hanahan, D.2
  • 20
    • 85017106819 scopus 로고    scopus 로고
    • Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists
    • Bani MR, Decio A, Giavazzi R, Ghilardi C (2017) Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists. Angiogenesis. doi:10.1007/s10456-017-9549-6
    • (2017) Angiogenesis
    • Bani, M.R.1    Decio, A.2    Giavazzi, R.3    Ghilardi, C.4
  • 21
    • 84930868061 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors in hematological malignancies and solid tumors
    • COI: 1:CAS:528:DC%2BC2MXit1aqu7g%3D
    • Chun P (2015) Histone deacetylase inhibitors in hematological malignancies and solid tumors. Arch Pharm Res 38(6):933–949
    • (2015) Arch Pharm Res , vol.38 , Issue.6 , pp. 933-949
    • Chun, P.1
  • 23
    • 0030916336 scopus 로고    scopus 로고
    • What’s up and down with histone deacetylation and transcription?
    • COI: 1:CAS:528:DyaK2sXjtFWisLY%3D
    • Pazin MJ, Kadonaga JT (1997) What’s up and down with histone deacetylation and transcription? Cell 89(3):325–328
    • (1997) Cell , vol.89 , Issue.3 , pp. 325-328
    • Pazin, M.J.1    Kadonaga, J.T.2
  • 24
    • 0030797585 scopus 로고    scopus 로고
    • Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
    • COI: 1:CAS:528:DyaK2sXlvFKmtLc%3D
    • Gu W, Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90(4):595–606
    • (1997) Cell , vol.90 , Issue.4 , pp. 595-606
    • Gu, W.1    Roeder, R.G.2
  • 25
    • 0032544123 scopus 로고    scopus 로고
    • Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases
    • COI: 1:CAS:528:DyaK1cXlsFSrt7g%3D
    • Zhang W, Bieker JJ (1998) Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases. Proc Natl Acad Sci USA 95(17):9855–9860
    • (1998) Proc Natl Acad Sci USA , vol.95 , Issue.17 , pp. 9855-9860
    • Zhang, W.1    Bieker, J.J.2
  • 26
    • 36048958965 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors: overview and perspectives
    • COI: 1:CAS:528:DC%2BD2sXhtFygsLvN
    • Dokmanovic M, Clarke C, Marks PA (2007) Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 5(10):981–989
    • (2007) Mol Cancer Res , vol.5 , Issue.10 , pp. 981-989
    • Dokmanovic, M.1    Clarke, C.2    Marks, P.A.3
  • 27
    • 37349089053 scopus 로고    scopus 로고
    • Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis
    • COI: 1:CAS:528:DC%2BD2sXhtlOjsL3N
    • Mottet D, Bellahcène A, Pirotte S, Waltregny D, Deroanne C, Lamour V, Lidereau R, Castronovo V (2007) Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis. Circ Res 101(12):1237–1246
    • (2007) Circ Res , vol.101 , Issue.12 , pp. 1237-1246
    • Mottet, D.1    Bellahcène, A.2    Pirotte, S.3    Waltregny, D.4    Deroanne, C.5    Lamour, V.6    Lidereau, R.7    Castronovo, V.8
  • 28
    • 33947313218 scopus 로고    scopus 로고
    • HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
    • COI: 1:CAS:528:DC%2BD2sXivVSmur0%3D
    • Gallinari P, Di Marco S, Jones P, Pallaoro M, Steinkühler C (2007) HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Res 17(3):195–211
    • (2007) Cell Res , vol.17 , Issue.3 , pp. 195-211
    • Gallinari, P.1    Di Marco, S.2    Jones, P.3    Pallaoro, M.4    Steinkühler, C.5
  • 29
    • 33744963443 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha
    • COI: 1:CAS:528:DC%2BD28Xkt1ymtLg%3D
    • Fath DM, Kong X, Liang D, Lin Z, Chou A, Jiang Y, Fang J, Caro J, Sang N (2006) Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha. J Biol Chem 281(19):13612–13619
    • (2006) J Biol Chem , vol.281 , Issue.19 , pp. 13612-13619
    • Fath, D.M.1    Kong, X.2    Liang, D.3    Lin, Z.4    Chou, A.5    Jiang, Y.6    Fang, J.7    Caro, J.8    Sang, N.9
  • 30
    • 76349095132 scopus 로고    scopus 로고
    • Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
    • COI: 1:CAS:528:DC%2BD1MXhsV2gt77N
    • Semenza GL (2010) Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29(5):625–634
    • (2010) Oncogene , vol.29 , Issue.5 , pp. 625-634
    • Semenza, G.L.1
  • 31
    • 50349091316 scopus 로고    scopus 로고
    • Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors
    • COI: 1:CAS:528:DC%2BD1cXmslygt7s%3D
    • Verheul HMW, Salumbides B, Van Erp K, Hammers H, Qian DZ, Sanni T, Atadja P, Pili R (2008) Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors. Clin Cancer Res 14(11):3589–3597
    • (2008) Clin Cancer Res , vol.14 , Issue.11 , pp. 3589-3597
    • Verheul, H.M.W.1    Salumbides, B.2    Van Erp, K.3    Hammers, H.4    Qian, D.Z.5    Sanni, T.6    Atadja, P.7    Pili, R.8
  • 32
    • 0038544192 scopus 로고    scopus 로고
    • Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents
    • COI: 1:CAS:528:DC%2BD3sXhtV2isbk%3D
    • Kim DH, Kim M, Kwon HJ (2003) Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents. J Biochem Mol Biol 36(1):110–119
    • (2003) J Biochem Mol Biol , vol.36 , Issue.1 , pp. 110-119
    • Kim, D.H.1    Kim, M.2    Kwon, H.J.3
  • 34
    • 16644379041 scopus 로고    scopus 로고
    • Valproic acid and interferon-alpha synergistically inhibit neuroblastoma cell growth in vitro and in vivo
    • COI: 1:CAS:528:DC%2BD2MXhsVyjsA%3D%3D
    • Michaelis M, Suhan T, Cinatl J, Driever PH, Cinatl J (2004) Valproic acid and interferon-alpha synergistically inhibit neuroblastoma cell growth in vitro and in vivo. Int J Oncol 25(6):1795–1799
    • (2004) Int J Oncol , vol.25 , Issue.6 , pp. 1795-1799
    • Michaelis, M.1    Suhan, T.2    Cinatl, J.3    Driever, P.H.4    Cinatl, J.5
  • 36
    • 67349201377 scopus 로고    scopus 로고
    • Targeting tumor angiogenesis with histone deacetylase inhibitors
    • COI: 1:CAS:528:DC%2BD1MXmsF2jt74%3D
    • Ellis L, Hammers H, Pili R (2009) Targeting tumor angiogenesis with histone deacetylase inhibitors. Cancer Lett 280(2):145–153
    • (2009) Cancer Lett , vol.280 , Issue.2 , pp. 145-153
    • Ellis, L.1    Hammers, H.2    Pili, R.3
  • 37
    • 33644780111 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1α
    • COI: 1:CAS:528:DC%2BD28Xislygt70%3D
    • Kong X, Lin Z, Liang D, Fath D (2006) Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1α. Mol Cell Biol 26(6):2019–2028
    • (2006) Mol Cell Biol , vol.26 , Issue.6 , pp. 2019-2028
    • Kong, X.1    Lin, Z.2    Liang, D.3    Fath, D.4
  • 38
    • 33845310374 scopus 로고    scopus 로고
    • Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications
    • COI: 1:CAS:528:DC%2BD2sXivVyqsLg%3D
    • Hellebrekers DMEI et al (2006) Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications. Cancer Res 66(22):10770–10777
    • (2006) Cancer Res , vol.66 , Issue.22 , pp. 10770-10777
    • Hellebrekers, D.M.E.I.1
  • 39
    • 78650443648 scopus 로고    scopus 로고
    • MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo
    • COI: 1:CAS:528:DC%2BC3cXhsFGrsLzE
    • Srivastava RK, Kurzrock R, Shankar S (2010) MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo. Mol Cancer Ther 9(12):3254–3266
    • (2010) Mol Cancer Ther , vol.9 , Issue.12 , pp. 3254-3266
    • Srivastava, R.K.1    Kurzrock, R.2    Shankar, S.3
  • 40
    • 0037225763 scopus 로고    scopus 로고
    • Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1alpha activity
    • Mie Lee Y, Kim S-H, Kim H-S, Jin Son M, Nakajima H, Jeong Kwon H, Kim K-W (2003) Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1alpha activity. Biochem Biophys Res Commun 300(1):241–246
    • (2003) Biochem Biophys Res Commun , vol.300 , Issue.1 , pp. 241-246
    • Mie Lee, Y.1    Kim, S.-H.2    Kim, H.-S.3    Jin Son, M.4    Nakajima, H.5    Jeong Kwon, H.6    Kim, K.-W.7
  • 41
    • 84919372520 scopus 로고    scopus 로고
    • New insights on chromatin modifiers and histone post-translational modifications in renal cell tumours
    • COI: 1:CAS:528:DC%2BC2cXitFSqt7bL
    • Vieira-Coimbra M, Henrique R, Jeronimo C (2015) New insights on chromatin modifiers and histone post-translational modifications in renal cell tumours. Eur J Clin Invest 45:16–24
    • (2015) Eur J Clin Invest , vol.45 , pp. 16-24
    • Vieira-Coimbra, M.1    Henrique, R.2    Jeronimo, C.3
  • 42
    • 33746228132 scopus 로고    scopus 로고
    • Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10
    • COI: 1:CAS:528:DC%2BD28Xot1OntL8%3D
    • Chang S, Young BD, Li S, Qi X, Richardson JA, Olson EN (2006) Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126(2):321–334
    • (2006) Cell , vol.126 , Issue.2 , pp. 321-334
    • Chang, S.1    Young, B.D.2    Li, S.3    Qi, X.4    Richardson, J.A.5    Olson, E.N.6
  • 43
    • 4744368147 scopus 로고    scopus 로고
    • Histone deacetylase 7 associates with hypoxia-inducible factor 1alpha and increases transcriptional activity
    • COI: 1:CAS:528:DC%2BD2cXnvFWnsL0%3D
    • Kato H, Tamamizu-Kato S, Shibasaki F (2004) Histone deacetylase 7 associates with hypoxia-inducible factor 1alpha and increases transcriptional activity. J Biol Chem 279(40):41966–41974
    • (2004) J Biol Chem , vol.279 , Issue.40 , pp. 41966-41974
    • Kato, H.1    Tamamizu-Kato, S.2    Shibasaki, F.3
  • 46
    • 85010866733 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism
    • COI: 1:CAS:528:DC%2BC2sXhs1Gis7s%3D
    • Hrgovic I, Doll M, Pinter A, Kaufmann R, Kippenberger S, Meissner M (2017) Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism. Exp Dermatol 26(2):194–201
    • (2017) Exp Dermatol , vol.26 , Issue.2 , pp. 194-201
    • Hrgovic, I.1    Doll, M.2    Pinter, A.3    Kaufmann, R.4    Kippenberger, S.5    Meissner, M.6
  • 47
    • 4644224489 scopus 로고    scopus 로고
    • VE-cadherin increases the half-life of VEGF receptor 2
    • COI: 1:CAS:528:DC%2BD2cXnslKrsL0%3D
    • Calera MR, Venkatakrishnan A, Kazlauskas A (2004) VE-cadherin increases the half-life of VEGF receptor 2. Exp Cell Res 300(1):248–256
    • (2004) Exp Cell Res , vol.300 , Issue.1 , pp. 248-256
    • Calera, M.R.1    Venkatakrishnan, A.2    Kazlauskas, A.3
  • 48
    • 84978180058 scopus 로고    scopus 로고
    • Trichostatin A, a histone deacetylase inhibitor suppresses NADPH Oxidase 4-Derived Redox Signalling and Angiogenesis
    • COI: 1:CAS:528:DC%2BC28XhsV2ksb3F
    • Hakami NY, Dusting GJ, Peshavariya HM (2016) Trichostatin A, a histone deacetylase inhibitor suppresses NADPH Oxidase 4-Derived Redox Signalling and Angiogenesis. J Cell Mol Med 20(10):1932–1944
    • (2016) J Cell Mol Med , vol.20 , Issue.10 , pp. 1932-1944
    • Hakami, N.Y.1    Dusting, G.J.2    Peshavariya, H.M.3
  • 50
    • 4644364508 scopus 로고    scopus 로고
    • The histone deacetylase inhibitor NVP-LAQ824 Inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584
    • COI: 1:CAS:528:DC%2BD2cXnsFOlu7w%3D
    • Qian DZ, Wang X, Kachhap SK, Kato Y, Wei Y, Zhang L, Atadja P, Pili R (2004) The histone deacetylase inhibitor NVP-LAQ824 Inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Cancer Res 64(18):6626–6634
    • (2004) Cancer Res , vol.64 , Issue.18 , pp. 6626-6634
    • Qian, D.Z.1    Wang, X.2    Kachhap, S.K.3    Kato, Y.4    Wei, Y.5    Zhang, L.6    Atadja, P.7    Pili, R.8
  • 51
    • 47849088748 scopus 로고    scopus 로고
    • Emerging roles of SIRT1 in vascular endothelial homeostasis
    • COI: 1:CAS:528:DC%2BD1cXhtVykurzK
    • Potente M, Dimmeler S (2008) Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle 7(14):2117–2122
    • (2008) Cell Cycle , vol.7 , Issue.14 , pp. 2117-2122
    • Potente, M.1    Dimmeler, S.2
  • 52
    • 34547875773 scopus 로고    scopus 로고
    • Sirtuins: critical regulators at the crossroads between cancer and aging
    • COI: 1:CAS:528:DC%2BD2sXovFersro%3D
    • Saunders LR, Verdin E (2007) Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 26(37):5489–5504
    • (2007) Oncogene , vol.26 , Issue.37 , pp. 5489-5504
    • Saunders, L.R.1    Verdin, E.2
  • 53
    • 84870203841 scopus 로고    scopus 로고
    • Anti-inflammatory properties of sirtuin 6 in human umbilical vein endothelial cells
    • Lappas M (2012) Anti-inflammatory properties of sirtuin 6 in human umbilical vein endothelial cells. Mediat Inflamm 2012:597514
    • (2012) Mediat Inflamm , vol.2012 , pp. 597514
    • Lappas, M.1
  • 54
    • 54149103338 scopus 로고    scopus 로고
    • Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice
    • COI: 1:CAS:528:DC%2BD1cXht1Knt7jI
    • Zhang Q-J, Wang Z, Chen H-Z, Zhou S, Zheng W, Liu G, Wei Y-S, Cai H, Liu D-P, Liang C-C (2008) Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res 80(2):191–199
    • (2008) Cardiovasc Res , vol.80 , Issue.2 , pp. 191-199
    • Zhang, Q.-J.1    Wang, Z.2    Chen, H.-Z.3    Zhou, S.4    Zheng, W.5    Liu, G.6    Wei, Y.-S.7    Cai, H.8    Liu, D.-P.9    Liang, C.-C.10
  • 55
    • 84994026397 scopus 로고    scopus 로고
    • Natural products as mechanism-based anticancer agents: Sp transcription factors as targets
    • COI: 1:CAS:528:DC%2BC28XhslOqurvO
    • Safe S, Kasiappan R (2016) Natural products as mechanism-based anticancer agents: Sp transcription factors as targets. Phyther Res 30(11):1723–1732
    • (2016) Phyther Res , vol.30 , Issue.11 , pp. 1723-1732
    • Safe, S.1    Kasiappan, R.2
  • 56
    • 84874459800 scopus 로고    scopus 로고
    • Cancer chemoprevention and nutri-epigenetics: state of the art and future challenges
    • Gerhauser C (2013) Cancer chemoprevention and nutri-epigenetics: state of the art and future challenges. Top Curr Chem 11(1):73–132
    • (2013) Top Curr Chem , vol.11 , Issue.1 , pp. 73-132
    • Gerhauser, C.1
  • 57
    • 51649092812 scopus 로고    scopus 로고
    • Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer—part 2
    • COI: 1:STN:280:DC%2BD2szmt1Whtg%3D%3D
    • Sagar SM, Yance D, Wong RK (2006) Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer—part 2. Curr Oncol 13(3):14–26
    • (2006) Curr Oncol , vol.13 , Issue.3 , pp. 14-26
    • Sagar, S.M.1    Yance, D.2    Wong, R.K.3
  • 58
    • 84913582432 scopus 로고    scopus 로고
    • Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer
    • COI: 1:CAS:528:DC%2BC2cXhvFCns7%2FF
    • Dhar S, Kumar A, Li K, Tzivion G, Levenson AS (2015) Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer. Biochim Biophys Acta Mol Cell Res 1853(2):265–275
    • (2015) Biochim Biophys Acta Mol Cell Res , vol.1853 , Issue.2 , pp. 265-275
    • Dhar, S.1    Kumar, A.2    Li, K.3    Tzivion, G.4    Levenson, A.S.5
  • 59
    • 84984706653 scopus 로고    scopus 로고
    • Cytotoxic effects of peanut phenolics possessing histone deacetylase inhibitory activity in breast and cervical cancer cell lines
    • COI: 1:CAS:528:DC%2BC28XhsVelt7vL
    • Saenglee S, Jogloy S, Patanothai A, Leid M, Senawong T (2016) Cytotoxic effects of peanut phenolics possessing histone deacetylase inhibitory activity in breast and cervical cancer cell lines. Pharmacol Rep 68(6):1102–1110
    • (2016) Pharmacol Rep , vol.68 , Issue.6 , pp. 1102-1110
    • Saenglee, S.1    Jogloy, S.2    Patanothai, A.3    Leid, M.4    Senawong, T.5
  • 61
    • 85007487828 scopus 로고    scopus 로고
    • Silibinin and colorectal cancer chemoprevention: a comprehensive review on mechanisms and efficacy
    • Raina K, Kumar S, Dhar D, Agarwal R (2016) Silibinin and colorectal cancer chemoprevention: a comprehensive review on mechanisms and efficacy. J Biomed Res 30(6):452–465
    • (2016) J Biomed Res , vol.30 , Issue.6 , pp. 452-465
    • Raina, K.1    Kumar, S.2    Dhar, D.3    Agarwal, R.4
  • 62
    • 84986004286 scopus 로고    scopus 로고
    • Silibinin inhibits hypoxia-induced HIF-1α–mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: in vitro evidence and in vivo functional imaging and metabolomics
    • Deep G, Kumar R, Nambiar DK, Jain AK, Ramteke AM, Serkova NJ, Agarwal C, Agarwal R (2016) Silibinin inhibits hypoxia-induced HIF-1α–mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: in vitro evidence and in vivo functional imaging and metabolomics. Mol Carcinog 56(3):833–848
    • (2016) Mol Carcinog , vol.56 , Issue.3 , pp. 833-848
    • Deep, G.1    Kumar, R.2    Nambiar, D.K.3    Jain, A.K.4    Ramteke, A.M.5    Serkova, N.J.6    Agarwal, C.7    Agarwal, R.8
  • 63
    • 0034675269 scopus 로고    scopus 로고
    • Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells
    • COI: 1:CAS:528:DC%2BD3cXmslKnurk%3D
    • Jiang C, Agarwal R, Lü J (2000) Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells. Biochem Biophys Res Commun 276(1):371–378
    • (2000) Biochem Biophys Res Commun , vol.276 , Issue.1 , pp. 371-378
    • Jiang, C.1    Agarwal, R.2    Lü, J.3
  • 64
    • 0141786950 scopus 로고    scopus 로고
    • Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis
    • COI: 1:CAS:528:DC%2BD3sXnsValt7c%3D
    • Singh RP, Sharma G, Dhanalakshmi S, Agarwal C, Agarwal R (2003) Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis. Cancer Epidemiol Biomark Prev 12(9):933–939
    • (2003) Cancer Epidemiol Biomark Prev , vol.12 , Issue.9 , pp. 933-939
    • Singh, R.P.1    Sharma, G.2    Dhanalakshmi, S.3    Agarwal, C.4    Agarwal, R.5
  • 65
    • 85006210753 scopus 로고    scopus 로고
    • Therapeutic intervention of silymarin on the migration of non-small cell lung cancer cells is associated with the axis of multiple molecular targets including class 1 HDACs, ZEB1 expression, and restoration of miR-203 and E-cadherin expression
    • Singh T, Prasad R, Katiyar SK (2016) Therapeutic intervention of silymarin on the migration of non-small cell lung cancer cells is associated with the axis of multiple molecular targets including class 1 HDACs, ZEB1 expression, and restoration of miR-203 and E-cadherin expression. Am J Cancer Res 6(6):1287–1301
    • (2016) Am J Cancer Res , vol.6 , Issue.6 , pp. 1287-1301
    • Singh, T.1    Prasad, R.2    Katiyar, S.K.3
  • 66
    • 0030459140 scopus 로고    scopus 로고
    • The role of DNA methylation in cancer genetics and epigenetics
    • COI: 1:CAS:528:DyaK2sXht12k
    • Laird PW, Jaenisch R (1996) The role of DNA methylation in cancer genetics and epigenetics. Annu Rev Genet 30(1):441–464
    • (1996) Annu Rev Genet , vol.30 , Issue.1 , pp. 441-464
    • Laird, P.W.1    Jaenisch, R.2
  • 67
    • 0024081657 scopus 로고
    • Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter
    • COI: 1:CAS:528:DyaL1cXmt1eksLk%3D
    • Watt F, Molloy PL (1988) Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev 2(9):1136–1143
    • (1988) Genes Dev , vol.2 , Issue.9 , pp. 1136-1143
    • Watt, F.1    Molloy, P.L.2
  • 68
    • 0031792779 scopus 로고    scopus 로고
    • Identification and characterization of a family of mammalian methyl-CpG binding proteins
    • COI: 1:CAS:528:DyaK1cXmvF2nsrg%3D
    • Hendrich B, Bird A (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 18(11):6538–6547
    • (1998) Mol Cell Biol , vol.18 , Issue.11 , pp. 6538-6547
    • Hendrich, B.1    Bird, A.2
  • 69
    • 0025975985 scopus 로고
    • DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein
    • COI: 1:CAS:528:DyaK3MXit1amu7Y%3D
    • Boyes J, Bird A (1991) DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 64(6):1123–1134
    • (1991) Cell , vol.64 , Issue.6 , pp. 1123-1134
    • Boyes, J.1    Bird, A.2
  • 70
    • 0032574977 scopus 로고    scopus 로고
    • Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
    • Bird A, Nan X, Ng H-H, Johnson CA, Laherty CD, Turner BM, Eisenman RN (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393(6683):386–389
    • (1998) Nature , vol.393 , Issue.6683 , pp. 386-389
    • Bird, A.1    Nan, X.2    Ng, H.-H.3    Johnson, C.A.4    Laherty, C.D.5    Turner, B.M.6    Eisenman, R.N.7
  • 71
    • 0031860739 scopus 로고    scopus 로고
    • Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases
    • COI: 1:CAS:528:DyaK1cXls1Sns7w%3D
    • Okano M, Xie S, Li E (1998) Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Am Inc 19(3):219–220
    • (1998) Nat Am Inc , vol.19 , Issue.3 , pp. 219-220
    • Okano, M.1    Xie, S.2    Li, E.3
  • 72
    • 0033615717 scopus 로고    scopus 로고
    • DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development
    • COI: 1:CAS:528:DyaK1MXnt1Gqsrc%3D
    • Okano M, Bell DW, Haber DA, Li E (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3):247–257
    • (1999) Cell , vol.99 , Issue.3 , pp. 247-257
    • Okano, M.1    Bell, D.W.2    Haber, D.A.3    Li, E.4
  • 73
    • 0028786951 scopus 로고
    • Loss of methylation activates Xist in somatic but not in embryonic cells
    • COI: 1:CAS:528:DyaK2MXos12itrY%3D
    • Beard C, Li E, Jaenisch R (1995) Loss of methylation activates Xist in somatic but not in embryonic cells. Genes Dev 9(19):2325–2334
    • (1995) Genes Dev , vol.9 , Issue.19 , pp. 2325-2334
    • Beard, C.1    Li, E.2    Jaenisch, R.3
  • 74
    • 0026697174 scopus 로고
    • Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain
    • COI: 1:CAS:528:DyaK38XkvVGrs70%3D
    • Bestor TH (1992) Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain. EMBO J 11(7):2611–2617
    • (1992) EMBO J , vol.11 , Issue.7 , pp. 2611-2617
    • Bestor, T.H.1
  • 75
    • 0026708177 scopus 로고
    • Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
    • COI: 1:CAS:528:DyaK38XksVGgsr0%3D
    • Li E, Bestor TH, Jaenisch R (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69(6):915–926
    • (1992) Cell , vol.69 , Issue.6 , pp. 915-926
    • Li, E.1    Bestor, T.H.2    Jaenisch, R.3
  • 76
    • 42549126341 scopus 로고    scopus 로고
    • Epigenetic regulation of vascular endothelial gene expression
    • COI: 1:CAS:528:DC%2BD1cXkvVemsr0%3D
    • Matouk CC, Marsden PA (2008) Epigenetic regulation of vascular endothelial gene expression. Circ Res 102(8):873–878
    • (2008) Circ Res , vol.102 , Issue.8 , pp. 873-878
    • Matouk, C.C.1    Marsden, P.A.2
  • 77
    • 78449302346 scopus 로고    scopus 로고
    • DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability
    • Şahin M, Şahin E, Gümüşlü S, Erdoǧan A, Gültekin M (2010) DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability. Cancer Metastasis Rev 29(4):655–676
    • (2010) Cancer Metastasis Rev , vol.29 , Issue.4 , pp. 655-676
    • Şahin, M.1    Şahin, E.2    Gümüşlü, S.3    Erdoǧan, A.4    Gültekin, M.5
  • 78
    • 77951695444 scopus 로고    scopus 로고
    • Aberrant methylation of thrombospondin-1 and its association with reduced expression in gastric cardia adenocarcinoma
    • Guo W, Dong Z, He M, Guo Y, Guo J, Chen Z, Yang Z, Kuang G (2010) Aberrant methylation of thrombospondin-1 and its association with reduced expression in gastric cardia adenocarcinoma. J Biomed Biotechnol. doi:10.1155/2010/721485
    • (2010) J Biomed Biotechnol
    • Guo, W.1    Dong, Z.2    He, M.3    Guo, Y.4    Guo, J.5    Chen, Z.6    Yang, Z.7    Kuang, G.8
  • 79
    • 84882686726 scopus 로고    scopus 로고
    • Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer
    • COI: 1:CAS:528:DC%2BC3sXhs1agsb%2FF
    • Zhang Y, Wang X, Xu B, Wang B, Wang Z, Liang Y, Zhou J, Hu J, Jiang B (2013) Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer. Oncol Rep 30(4):1976–1984
    • (2013) Oncol Rep , vol.30 , Issue.4 , pp. 1976-1984
    • Zhang, Y.1    Wang, X.2    Xu, B.3    Wang, B.4    Wang, Z.5    Liang, Y.6    Zhou, J.7    Hu, J.8    Jiang, B.9
  • 81
    • 70349656779 scopus 로고    scopus 로고
    • Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer
    • Bo BL, Eun JL, Eun HJ, Chun HK, Dong KC, Sang YS, Park J, Kim DH (2009) Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. Clin Cancer Res 15(19):6185–6191
    • (2009) Clin Cancer Res , vol.15 , Issue.19 , pp. 6185-6191
    • Bo, B.L.1    Eun, J.L.2    Eun, H.J.3    Chun, H.K.4    Dong, K.C.5    Sang, Y.S.6    Park, J.7    Kim, D.H.8
  • 82
    • 68349139365 scopus 로고    scopus 로고
    • Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
    • Veeck J, Wild PJ, Fuchs T, Schüffler PJ, Hartmann A, Knüchel R, Dahl E (2009) Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer. BMC Cancer. doi:10.1186/1471-2407-9-217
    • (2009) BMC Cancer
    • Veeck, J.1    Wild, P.J.2    Fuchs, T.3    Schüffler, P.J.4    Hartmann, A.5    Knüchel, R.6    Dahl, E.7
  • 83
    • 84893694694 scopus 로고    scopus 로고
    • Wif1 hypermethylation as unfavorable prognosis of non-small cell lung cancers with EGFR mutation
    • COI: 1:CAS:528:DC%2BC3sXhtFGmurnI
    • Lee SM, Park JY, Kim DS (2013) Wif1 hypermethylation as unfavorable prognosis of non-small cell lung cancers with EGFR mutation. Mol Cells 36(1):69–73
    • (2013) Mol Cells , vol.36 , Issue.1 , pp. 69-73
    • Lee, S.M.1    Park, J.Y.2    Kim, D.S.3
  • 85
    • 14044278776 scopus 로고    scopus 로고
    • Glycogen-synthase kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells
    • COI: 1:CAS:528:DC%2BD2MXhtF2nsLc%3D
    • Skurk C, Maatz H, Rocnik E, Bialik A, Force T, Walsh K (2005) Glycogen-synthase kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells. Circ Res 96(3):308–318
    • (2005) Circ Res , vol.96 , Issue.3 , pp. 308-318
    • Skurk, C.1    Maatz, H.2    Rocnik, E.3    Bialik, A.4    Force, T.5    Walsh, K.6
  • 86
    • 79956328903 scopus 로고    scopus 로고
    • Molecular mechanisms and clinical applications of angiogenesis
    • COI: 1:CAS:528:DC%2BC3MXmtlemurg%3D
    • Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298–307
    • (2011) Nature , vol.473 , Issue.7347 , pp. 298-307
    • Carmeliet, P.1    Jain, R.K.2
  • 88
    • 58549108465 scopus 로고    scopus 로고
    • Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells
    • COI: 1:CAS:528:DC%2BD1MXhtFemt7w%3D
    • Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, Liang G (2009) Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 379(3):726–731
    • (2009) Biochem Biophys Res Commun , vol.379 , Issue.3 , pp. 726-731
    • Saito, Y.1    Friedman, J.M.2    Chihara, Y.3    Egger, G.4    Chuang, J.C.5    Liang, G.6
  • 90
    • 84875808286 scopus 로고    scopus 로고
    • Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis
    • COI: 1:CAS:528:DC%2BC38XhvVektrzK
    • Lindner DJ, Wu Y, Haney R, Jacobs BS, Fruehauf JP, Tuthill R, Borden EC (2013) Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis. Matrix Biol 32(2):123–132
    • (2013) Matrix Biol , vol.32 , Issue.2 , pp. 123-132
    • Lindner, D.J.1    Wu, Y.2    Haney, R.3    Jacobs, B.S.4    Fruehauf, J.P.5    Tuthill, R.6    Borden, E.C.7
  • 91
    • 65849274263 scopus 로고    scopus 로고
    • Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments
    • COI: 1:CAS:528:DC%2BD1cXht1ygt7fI
    • Mirochnik Y, Kwiatek A, Volpert O (2008) Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments. Curr Drug Targets 9(10):851–862
    • (2008) Curr Drug Targets , vol.9 , Issue.10 , pp. 851-862
    • Mirochnik, Y.1    Kwiatek, A.2    Volpert, O.3
  • 93
    • 78449267307 scopus 로고    scopus 로고
    • DLC1 negatively regulates angiogenesis in a paracrine fashion
    • COI: 1:CAS:528:DC%2BC3cXhtlKjtrjE
    • Shih YP, Liao YC, Lin Y, Lo SH (2010) DLC1 negatively regulates angiogenesis in a paracrine fashion. Cancer Res 70(21):8270–8275
    • (2010) Cancer Res , vol.70 , Issue.21 , pp. 8270-8275
    • Shih, Y.P.1    Liao, Y.C.2    Lin, Y.3    Lo, S.H.4
  • 94
    • 48149105835 scopus 로고    scopus 로고
    • Anti-angiogenesis: making the tumor vulnerable to the immune system
    • COI: 1:CAS:528:DC%2BD1cXovFyitr8%3D
    • Griffioen AW (2008) Anti-angiogenesis: making the tumor vulnerable to the immune system. Cancer Immunol Immunother 57(10):1553–1558
    • (2008) Cancer Immunol Immunother , vol.57 , Issue.10 , pp. 1553-1558
    • Griffioen, A.W.1
  • 96
    • 84908696558 scopus 로고    scopus 로고
    • The RECK gene and biological malignancy-its significance in angiogenesis and inhibition of matrix metalloproteinases
    • COI: 1:CAS:528:DC%2BC2cXhsFKrsr3N
    • Alexius-Lindgren M, Andersson E, Lindstedt I, Engström W (2014) The RECK gene and biological malignancy-its significance in angiogenesis and inhibition of matrix metalloproteinases. Anticancer Res 34(8):3867–3874
    • (2014) Anticancer Res , vol.34 , Issue.8 , pp. 3867-3874
    • Alexius-Lindgren, M.1    Andersson, E.2    Lindstedt, I.3    Engström, W.4
  • 97
    • 0142148099 scopus 로고    scopus 로고
    • Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram
    • Shian S-G, Kao Y-R, Wu FY-H, Wu C-W (2003) Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram. Mol Pharmacol 64(5):1076–1084
    • (2003) Mol Pharmacol , vol.64 , Issue.5 , pp. 1076-1084
    • Shian, S.-G.1    Kao, Y.-R.2    Wu, F.Y.-H.3    Wu, C.-W.4
  • 101
    • 84961167044 scopus 로고    scopus 로고
    • In vitro and in vivo study of hydralazine, a potential anti-angiogenic agent
    • COI: 1:CAS:528:DC%2BC28XksVWht70%3D
    • Zhang Q, Lin Z, Yin X, Tang L, Luo H, Li H, Zhang Y, Luo W (2016) In vitro and in vivo study of hydralazine, a potential anti-angiogenic agent. Eur J Pharmacol 779:138–146
    • (2016) Eur J Pharmacol , vol.779 , pp. 138-146
    • Zhang, Q.1    Lin, Z.2    Yin, X.3    Tang, L.4    Luo, H.5    Li, H.6    Zhang, Y.7    Luo, W.8
  • 102
    • 84885646525 scopus 로고    scopus 로고
    • Epigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1α and VEGF expression
    • Li X, Feng Y, Liu J, Feng X, Zhou K, Tang X (2013) Epigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1α and VEGF expression. J Nutrigenet Nutrigenom 6(3):169–178
    • (2013) J Nutrigenet Nutrigenom , vol.6 , Issue.3 , pp. 169-178
    • Li, X.1    Feng, Y.2    Liu, J.3    Feng, X.4    Zhou, K.5    Tang, X.6
  • 103
    • 84884632449 scopus 로고    scopus 로고
    • Effects of epigallocatechin-3-gallate (EGCG) on A549 lung cancer tumor growth and angiogenesis
    • COI: 1:CAS:528:DC%2BC3sXhsF2ksbrF
    • Sakamoto Y, Terashita N, Muraguchi T, Fukusato T, Kubota S (2013) Effects of epigallocatechin-3-gallate (EGCG) on A549 lung cancer tumor growth and angiogenesis. Biosci Biotechnol Biochem 77(9):1799–1803
    • (2013) Biosci Biotechnol Biochem , vol.77 , Issue.9 , pp. 1799-1803
    • Sakamoto, Y.1    Terashita, N.2    Muraguchi, T.3    Fukusato, T.4    Kubota, S.5
  • 104
    • 84877314894 scopus 로고    scopus 로고
    • EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1alpha and NFkappaB, and VEGF expression
    • COI: 1:CAS:528:DC%2BC3sXot1ygtbY%3D
    • Gu J, Makey KL, Tucker KB, Chinchar E, Mao X, Pei I, Thomas EY, Miele L (2013) EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1alpha and NFkappaB, and VEGF expression. Vasc Cell 5(1):9
    • (2013) Vasc Cell , vol.5 , Issue.1 , pp. 9
    • Gu, J.1    Makey, K.L.2    Tucker, K.B.3    Chinchar, E.4    Mao, X.5    Pei, I.6    Thomas, E.Y.7    Miele, L.8
  • 105
    • 49549087270 scopus 로고    scopus 로고
    • Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells
    • COI: 1:CAS:528:DC%2BD1cXpslWrt7c%3D
    • Kato K, Long NK, Makita H, Toida M, Yamashita T, Hatakeyama D, Hara A, Mori H, Shibata T (2008) Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br J Cancer 99(4):647–654
    • (2008) Br J Cancer , vol.99 , Issue.4 , pp. 647-654
    • Kato, K.1    Long, N.K.2    Makita, H.3    Toida, M.4    Yamashita, T.5    Hatakeyama, D.6    Hara, A.7    Mori, H.8    Shibata, T.9
  • 106
    • 51349137454 scopus 로고    scopus 로고
    • Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins
    • COI: 1:CAS:528:DC%2BD1cXhtFWlsrjM
    • Kunnumakkara AB, Anand P, Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269(2):199–225
    • (2008) Cancer Lett , vol.269 , Issue.2 , pp. 199-225
    • Kunnumakkara, A.B.1    Anand, P.2    Aggarwal, B.B.3
  • 108
    • 84873710074 scopus 로고    scopus 로고
    • Reactivation of RASSF1A in breast cancer cells by curcumin
    • COI: 1:CAS:528:DC%2BC38Xhs1OmsrbO
    • Du L, Xie Z, Wu LC, Chiu M, Lin J, Chan KK, Liu S, Liu Z (2012) Reactivation of RASSF1A in breast cancer cells by curcumin. Nutr Cancer Int J 64(8):1228–1235
    • (2012) Nutr Cancer Int J , vol.64 , Issue.8 , pp. 1228-1235
    • Du, L.1    Xie, Z.2    Wu, L.C.3    Chiu, M.4    Lin, J.5    Chan, K.K.6    Liu, S.7    Liu, Z.8
  • 109
    • 84876084653 scopus 로고    scopus 로고
    • Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins
    • Mirza S, Sharma G, Parshad R, Gupta SD, Pandya P, Ralhan R (2013) Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. J Breast Cancer 16(1):23–31
    • (2013) J Breast Cancer , vol.16 , Issue.1 , pp. 23-31
    • Mirza, S.1    Sharma, G.2    Parshad, R.3    Gupta, S.D.4    Pandya, P.5    Ralhan, R.6
  • 110
    • 84883387232 scopus 로고    scopus 로고
    • Curcumin as a regulator of epigenetic events
    • COI: 1:CAS:528:DC%2BC3sXptV2gtrk%3D
    • Teiten MH, Dicato M, Diederich M (2013) Curcumin as a regulator of epigenetic events. Mol Nutr Food Res 57(9):1619–1629
    • (2013) Mol Nutr Food Res , vol.57 , Issue.9 , pp. 1619-1629
    • Teiten, M.H.1    Dicato, M.2    Diederich, M.3
  • 111
    • 84864357972 scopus 로고    scopus 로고
    • Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer
    • COI: 1:CAS:528:DC%2BC38XhtVOisr3I
    • Alexandrow MG, Song LJ, Altiok S, Gray J, Haura EB, Kumar NB (2012) Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer. Eur J Cancer Prev 21(5):407–412
    • (2012) Eur J Cancer Prev , vol.21 , Issue.5 , pp. 407-412
    • Alexandrow, M.G.1    Song, L.J.2    Altiok, S.3    Gray, J.4    Haura, E.B.5    Kumar, N.B.6
  • 113
    • 0037461934 scopus 로고    scopus 로고
    • Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis
    • COI: 1:CAS:528:DC%2BD3sXlsV2ltA%3D%3D
    • Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K (2003) Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 22(3):319–329
    • (2003) Oncogene , vol.22 , Issue.3 , pp. 319-329
    • Wei, D.1    Le, X.2    Zheng, L.3    Wang, L.4    Frey, J.A.5    Gao, A.C.6    Peng, Z.7    Huang, S.8    Xiong, H.Q.9    Abbruzzese, J.L.10    Xie, K.11
  • 114
    • 84861215508 scopus 로고    scopus 로고
    • Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation
    • COI: 1:CAS:528:DC%2BC38Xot1Kntrw%3D
    • Lee H, Zhang P, Herrmann A, Yang C, Xin H, Wang Z, Hoon DSB, Forman SJ, Jove R, Riggs AD, Yu H (2012) Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation. Proc Natl Acad Sci 109(20):7765–7769
    • (2012) Proc Natl Acad Sci , vol.109 , Issue.20 , pp. 7765-7769
    • Lee, H.1    Zhang, P.2    Herrmann, A.3    Yang, C.4    Xin, H.5    Wang, Z.6    Hoon, D.S.B.7    Forman, S.J.8    Jove, R.9    Riggs, A.D.10    Yu, H.11
  • 115
    • 84959550810 scopus 로고    scopus 로고
    • Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis
    • Huang L, Hu B, Ni J, Wu J, Jiang W, Chen C, Yang L, Zeng Y, Wan R, Hu G, Wang X (2016) Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis. J Exp Clin Cancer Res 35(1):27
    • (2016) J Exp Clin Cancer Res , vol.35 , Issue.1 , pp. 27
    • Huang, L.1    Hu, B.2    Ni, J.3    Wu, J.4    Jiang, W.5    Chen, C.6    Yang, L.7    Zeng, Y.8    Wan, R.9    Hu, G.10    Wang, X.11
  • 120
  • 121
    • 84959211586 scopus 로고    scopus 로고
    • Metal-based drugs that break the rules
    • COI: 1:CAS:528:DC%2BC28XhsFymurs%3D
    • Allardyce CS, Dyson PJ (2016) Metal-based drugs that break the rules. Dalton Trans 45(8):3201–3209
    • (2016) Dalton Trans , vol.45 , Issue.8 , pp. 3201-3209
    • Allardyce, C.S.1    Dyson, P.J.2
  • 122
    • 84896071887 scopus 로고    scopus 로고
    • Anti-cancer drug KP1019 modulates epigenetics and induces DNA damage response in Saccharomyces cerevisiae
    • COI: 1:CAS:528:DC%2BC2cXjtlSrsrc%3D
    • Singh V, Azad GK, Mandal P, Amarendar Reddy M, Tomar RS (2014) Anti-cancer drug KP1019 modulates epigenetics and induces DNA damage response in Saccharomyces cerevisiae. FEBS Lett 588(6):1044–1052
    • (2014) FEBS Lett , vol.588 , Issue.6 , pp. 1044-1052
    • Singh, V.1    Azad, G.K.2    Mandal, P.3    Amarendar Reddy, M.4    Tomar, R.S.5
  • 124
    • 2542625358 scopus 로고    scopus 로고
    • A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
    • COI: 1:CAS:528:DC%2BD2cXksVKntr8%3D
    • Rademaker-Lakhai JM, Van Den Bongard D, Pluim D, Beijnen JH, Schellens JHM (2004) A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent. Clin Cancer Res 10:3717–3727
    • (2004) Clin Cancer Res , vol.10 , pp. 3717-3727
    • Rademaker-Lakhai, J.M.1    Van Den Bongard, D.2    Pluim, D.3    Beijnen, J.H.4    Schellens, J.H.M.5
  • 125
    • 58149339989 scopus 로고    scopus 로고
    • KP1019, a new redox-active anticancer agent—preclinical development and results of a clinical phase I study in tumor patients
    • COI: 1:CAS:528:DC%2BD1cXhsVWktLvO
    • Hartinger CG, Jakupec MA, Zorbas-Seifried S, Groessl M, Egger A, Berger W, Zorbas H, Dyson PJ, Keppler BK (2008) KP1019, a new redox-active anticancer agent—preclinical development and results of a clinical phase I study in tumor patients. Chem Biodivers 5(10):2140–2155
    • (2008) Chem Biodivers , vol.5 , Issue.10 , pp. 2140-2155
    • Hartinger, C.G.1    Jakupec, M.A.2    Zorbas-Seifried, S.3    Groessl, M.4    Egger, A.5    Berger, W.6    Zorbas, H.7    Dyson, P.J.8    Keppler, B.K.9
  • 126
    • 84903745805 scopus 로고    scopus 로고
    • NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
    • COI: 1:CAS:528:DC%2BC2cXhtVOiurbM
    • Trondl R, Heffeter P, Kowol CR, Jakupec MA, Berger W, Keppler BK (2014) NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application. Chem Sci 5(8):2925
    • (2014) Chem Sci , vol.5 , Issue.8 , pp. 2925
    • Trondl, R.1    Heffeter, P.2    Kowol, C.R.3    Jakupec, M.A.4    Berger, W.5    Keppler, B.K.6
  • 127
    • 0037987890 scopus 로고    scopus 로고
    • Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers
    • COI: 1:CAS:528:DC%2BD3sXktFOgu7w%3D
    • Morbidelli L, Donnini S, Filippi S, Messori L, Piccioli F, Orioli P, Sava G, Ziche M (2003) Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers. Br J Cancer 88(9):1484–1491
    • (2003) Br J Cancer , vol.88 , Issue.9 , pp. 1484-1491
    • Morbidelli, L.1    Donnini, S.2    Filippi, S.3    Messori, L.4    Piccioli, F.5    Orioli, P.6    Sava, G.7    Ziche, M.8
  • 128
    • 0036445261 scopus 로고    scopus 로고
    • Inhibition of the MEK/ERK signaling pathway by the novel antimetastatic agent NAMI-A down regulates c-myc gene expression and endothelial cell proliferation
    • COI: 1:CAS:528:DC%2BD38XpsVOqt7g%3D
    • Pintus G, Tadolini B, Posadino AM, Sanna B, Debidda M, Bennardini F, Sava G, Ventura C (2002) Inhibition of the MEK/ERK signaling pathway by the novel antimetastatic agent NAMI-A down regulates c-myc gene expression and endothelial cell proliferation. Eur J Biochem 269(23):5861–5870
    • (2002) Eur J Biochem , vol.269 , Issue.23 , pp. 5861-5870
    • Pintus, G.1    Tadolini, B.2    Posadino, A.M.3    Sanna, B.4    Debidda, M.5    Bennardini, F.6    Sava, G.7    Ventura, C.8
  • 129
  • 130
    • 62449161586 scopus 로고    scopus 로고
    • Bioorganometallic chemistry–from teaching paradigms to medicinal applications
    • COI: 1:CAS:528:DC%2BD1MXksVSntLs%3D
    • Hartinger CG, Dyson PJ (2009) Bioorganometallic chemistry–from teaching paradigms to medicinal applications. Chem Soc Rev 38(2):391–401
    • (2009) Chem Soc Rev , vol.38 , Issue.2 , pp. 391-401
    • Hartinger, C.G.1    Dyson, P.J.2
  • 131
    • 80053999836 scopus 로고    scopus 로고
    • Targeted and multifunctional arene ruthenium chemotherapeutics
    • COI: 1:CAS:528:DC%2BC3MXhtlShu73J
    • Smith GS, Therrien B (2011) Targeted and multifunctional arene ruthenium chemotherapeutics. Dalton Trans 40(41):10793
    • (2011) Dalton Trans , vol.40 , Issue.41 , pp. 10793
    • Smith, G.S.1    Therrien, B.2
  • 132
    • 84893262070 scopus 로고    scopus 로고
    • Water-soluble arene ruthenium complexes: from serendipity to catalysis and drug design
    • Süss-Fink G (2014) Water-soluble arene ruthenium complexes: from serendipity to catalysis and drug design. J Organomet Chem 751:2–19
    • (2014) J Organomet Chem , vol.751 , pp. 2-19
    • Süss-Fink, G.1
  • 133
    • 84982077068 scopus 로고    scopus 로고
    • The development of RAPTA compounds for the treatment of tumors
    • COI: 1:CAS:528:DC%2BC2MXhtFCqtL7M
    • Murray BS, Babak MV, Hartinger CG, Dyson PJ (2016) The development of RAPTA compounds for the treatment of tumors. Coord Chem Rev 306:86–114
    • (2016) Coord Chem Rev , vol.306 , pp. 86-114
    • Murray, B.S.1    Babak, M.V.2    Hartinger, C.G.3    Dyson, P.J.4
  • 137
    • 33749011163 scopus 로고    scopus 로고
    • The NCI60 human tumour cell line anticancer drug screen
    • COI: 1:CAS:528:DC%2BD28XpvVCmu7c%3D
    • Shoemaker RH (2006) The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 6(10):813–823
    • (2006) Nat Rev Cancer , vol.6 , Issue.10 , pp. 813-823
    • Shoemaker, R.H.1
  • 139
    • 84907593135 scopus 로고    scopus 로고
    • The chicken chorioallantoic membrane model in biology, medicine and bioengineering
    • Nowak-Sliwinska P, Segura T, Iruela-Arispe ML (2014) The chicken chorioallantoic membrane model in biology, medicine and bioengineering. Angiogenesis 4:779–804
    • (2014) Angiogenesis , vol.4 , pp. 779-804
    • Nowak-Sliwinska, P.1    Segura, T.2    Iruela-Arispe, M.L.3
  • 140
    • 84946780107 scopus 로고    scopus 로고
    • NanoSIMS analysis of an isotopically labelled organometallic ruthenium(II) drug to probe its distribution and state in vitro
    • COI: 1:CAS:528:DC%2BC2MXhsFCitr3E
    • Lee RFS, Escrig S, Croisier M, Clerc-Rosset S, Knott GW, Meibom A, Davey CA, Johnsson K, Dyson PJ (2015) NanoSIMS analysis of an isotopically labelled organometallic ruthenium(II) drug to probe its distribution and state in vitro. Chem Commun (Camb) 51(92):16486–16489
    • (2015) Chem Commun (Camb) , vol.51 , Issue.92 , pp. 16486-16489
    • Lee, R.F.S.1    Escrig, S.2    Croisier, M.3    Clerc-Rosset, S.4    Knott, G.W.5    Meibom, A.6    Davey, C.A.7    Johnsson, K.8    Dyson, P.J.9
  • 141
    • 79952593681 scopus 로고    scopus 로고
    • A ruthenium antimetastasis agent forms specific histone protein adducts in the nucleosome core
    • COI: 1:CAS:528:DC%2BC3MXjtFWnsLk%3D
    • Wu B, Ong MS, Groessl M, Adhireksan Z, Hartinger CG, Dyson PJ, Davey CA (2011) A ruthenium antimetastasis agent forms specific histone protein adducts in the nucleosome core. Chemistry 17(13):3562–3566
    • (2011) Chemistry , vol.17 , Issue.13 , pp. 3562-3566
    • Wu, B.1    Ong, M.S.2    Groessl, M.3    Adhireksan, Z.4    Hartinger, C.G.5    Dyson, P.J.6    Davey, C.A.7
  • 143
    • 85019530384 scopus 로고    scopus 로고
    • Current trends in multidrug optimization
    • Weiss A, Nowak-Sliwinska P (2016) Current trends in multidrug optimization. J Lab Autom. doi:10.1177/2211068216682338
    • (2016) J Lab Autom
    • Weiss, A.1    Nowak-Sliwinska, P.2
  • 148
    • 84869453615 scopus 로고    scopus 로고
    • Cytotoxic effects of Jay Amin hydroxamic acid (JAHA), a ferrocene-based class i histone deacetylase inhibitor, on triple-negative MDA-MB231 breast cancer cells
    • COI: 1:CAS:528:DC%2BC38XhsFGmtLnM
    • Librizzi M, Longo A, Chiarelli R, Amin J, Spencer J, Luparello C (2012) Cytotoxic effects of Jay Amin hydroxamic acid (JAHA), a ferrocene-based class i histone deacetylase inhibitor, on triple-negative MDA-MB231 breast cancer cells. Chem Res Toxicol 25(11):2608–2616
    • (2012) Chem Res Toxicol , vol.25 , Issue.11 , pp. 2608-2616
    • Librizzi, M.1    Longo, A.2    Chiarelli, R.3    Amin, J.4    Spencer, J.5    Luparello, C.6
  • 149
    • 78751590899 scopus 로고    scopus 로고
    • Silencing chromatin: comparing modes and mechanisms
    • COI: 1:CAS:528:DC%2BC3MXmsVelsQ%3D%3D
    • Beisel C, Paro R (2011) Silencing chromatin: comparing modes and mechanisms. Nat Rev Genet 12(2):123–135
    • (2011) Nat Rev Genet , vol.12 , Issue.2 , pp. 123-135
    • Beisel, C.1    Paro, R.2
  • 150
    • 0033919595 scopus 로고    scopus 로고
    • DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters
    • COI: 1:CAS:528:DC%2BD3cXkvFKkt7Y%3D
    • Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP (2000) DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 25(3):338–342
    • (2000) Nat Genet , vol.25 , Issue.3 , pp. 338-342
    • Robertson, K.D.1    Ait-Si-Ali, S.2    Yokochi, T.3    Wade, P.A.4    Jones, P.L.5    Wolffe, A.P.6
  • 151
    • 0033945861 scopus 로고    scopus 로고
    • DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
    • COI: 1:CAS:528:DC%2BD3cXkvFKltLk%3D
    • Rountree MR, Bachman KE, Baylin SB (2000) DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet 25(3):269–277
    • (2000) Nat Genet , vol.25 , Issue.3 , pp. 269-277
    • Rountree, M.R.1    Bachman, K.E.2    Baylin, S.B.3
  • 152
    • 84893742589 scopus 로고    scopus 로고
    • Epigenetic modulators mitigate angiogenesis through a complex transcriptomic network
    • COI: 1:CAS:528:DC%2BC2cXhsFensrk%3D
    • Shiva Shankar TV, Willems L (2014) Epigenetic modulators mitigate angiogenesis through a complex transcriptomic network. Vasc Pharmacol 60(2):57–66
    • (2014) Vasc Pharmacol , vol.60 , Issue.2 , pp. 57-66
    • Shiva Shankar, T.V.1    Willems, L.2
  • 153
    • 0000346996 scopus 로고    scopus 로고
    • Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation
    • COI: 1:CAS:528:DC%2BD3cXjvVGhtw%3D%3D
    • Chen WY, Townes TM (2000) Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation. Proc Natl Acad Sci USA 97(1):377–382
    • (2000) Proc Natl Acad Sci USA , vol.97 , Issue.1 , pp. 377-382
    • Chen, W.Y.1    Townes, T.M.2
  • 154
    • 84863872956 scopus 로고    scopus 로고
    • Epigenetic interplay of histone modifications and DNA methylation mediated by HDA6
    • COI: 1:CAS:528:DC%2BC38XhslSktr%2FN
    • Liu X, Luo M, Wu K (2012) Epigenetic interplay of histone modifications and DNA methylation mediated by HDA6. Plant Signal Behav 7(6):633–635
    • (2012) Plant Signal Behav , vol.7 , Issue.6 , pp. 633-635
    • Liu, X.1    Luo, M.2    Wu, K.3
  • 156
    • 0032482974 scopus 로고    scopus 로고
    • Trichostatin A causes selective loss of DNA methylation in Neurospora
    • COI: 1:CAS:528:DyaK1cXltlClsrk%3D
    • Selker EU (1998) Trichostatin A causes selective loss of DNA methylation in Neurospora. Proc Natl Acad Sci USA 95(16):9430–9435
    • (1998) Proc Natl Acad Sci USA , vol.95 , Issue.16 , pp. 9430-9435
    • Selker, E.U.1
  • 157
    • 51049117752 scopus 로고    scopus 로고
    • Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells
    • COI: 1:CAS:528:DC%2BD1cXmt1Ojsbo%3D
    • Zhou Q, Agoston AT, Atadja P, Nelson WG, Davidson NE (2008) Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells. Mol Cancer Res 6(5):873–883
    • (2008) Mol Cancer Res , vol.6 , Issue.5 , pp. 873-883
    • Zhou, Q.1    Agoston, A.T.2    Atadja, P.3    Nelson, W.G.4    Davidson, N.E.5
  • 158
    • 47849083984 scopus 로고    scopus 로고
    • Epigenetic interplay between histone modifications and DNA methylation in gene silencing
    • Vaissière T, Sawan C, Herceg Z (2008) Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res 659(1–2):40–48
    • (2008) Mutat Res , vol.659 , Issue.1-2 , pp. 40-48
    • Vaissière, T.1    Sawan, C.2    Herceg, Z.3
  • 159
    • 67349190247 scopus 로고    scopus 로고
    • Linking DNA methylation and histone modification: patterns and paradigms
    • COI: 1:CAS:528:DC%2BD1MXksF2rsL0%3D
    • Cedar H, Bergman Y (2009) Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 10(5):295–304
    • (2009) Nat Rev Genet , vol.10 , Issue.5 , pp. 295-304
    • Cedar, H.1    Bergman, Y.2
  • 160
    • 84888811617 scopus 로고    scopus 로고
    • Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma
    • COI: 1:CAS:528:DC%2BC2cXntlWnsL4%3D
    • Lyu T, Jia N, Wang J, Yan X, Yu Y, Lu Z, Bast RC, Hua K, Feng W (2013) Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma. Epigenetics 8(12):1330–1346
    • (2013) Epigenetics , vol.8 , Issue.12 , pp. 1330-1346
    • Lyu, T.1    Jia, N.2    Wang, J.3    Yan, X.4    Yu, Y.5    Lu, Z.6    Bast, R.C.7    Hua, K.8    Feng, W.9
  • 162
    • 0032948005 scopus 로고    scopus 로고
    • Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
    • COI: 1:CAS:528:DyaK1MXltlWjtA%3D%3D
    • Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21(1):103–107
    • (1999) Nat Genet , vol.21 , Issue.1 , pp. 103-107
    • Cameron, E.E.1    Bachman, K.E.2    Myohanen, S.3    Herman, J.G.4    Baylin, S.B.5
  • 163
    • 77953196949 scopus 로고    scopus 로고
    • p16 Modulates VEGF expression via its interaction with HIF-1alpha in breast cancer cells
    • COI: 1:CAS:528:DC%2BC3cXpslOltLk%3D
    • Zhang J, Lu A, Li L, Yue J, Lu Y (2010) p16 Modulates VEGF expression via its interaction with HIF-1alpha in breast cancer cells. Cancer Invest 28(6):588–597
    • (2010) Cancer Invest , vol.28 , Issue.6 , pp. 588-597
    • Zhang, J.1    Lu, A.2    Li, L.3    Yue, J.4    Lu, Y.5
  • 164
    • 0034571056 scopus 로고    scopus 로고
    • Demethylation by 5-aza-2′-deoxycytidine (5-azadC) of p16INK4A gene results in downregulation of vascular endothelial growth factor expression in human lung cancer cell lines
    • COI: 1:STN:280:DC%2BD3Mrkt1Gitw%3D%3D
    • Miki K, Shimizu E, Yano S, Tani K, Sone S (2001) Demethylation by 5-aza-2′-deoxycytidine (5-azadC) of p16INK4A gene results in downregulation of vascular endothelial growth factor expression in human lung cancer cell lines. Oncol Res 12(8):335–342
    • (2001) Oncol Res , vol.12 , Issue.8 , pp. 335-342
    • Miki, K.1    Shimizu, E.2    Yano, S.3    Tani, K.4    Sone, S.5
  • 165
    • 0030323007 scopus 로고    scopus 로고
    • A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth
    • COI: 1:CAS:528:DyaK2sXjsVGrsro%3D
    • Anand-Apte B, Bao L, Smith R, Iwata K, Olsen BR, Zetter B, Apte SS (1996) A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochem Cell Biol 74(6):853–862
    • (1996) Biochem Cell Biol , vol.74 , Issue.6 , pp. 853-862
    • Anand-Apte, B.1    Bao, L.2    Smith, R.3    Iwata, K.4    Olsen, B.R.5    Zetter, B.6    Apte, S.S.7
  • 166
    • 0037393850 scopus 로고    scopus 로고
    • A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2
    • COI: 1:CAS:528:DC%2BD3sXisVOmu7k%3D
    • Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M, Baker A, Anand-Apte B (2003) A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 9(4):407–415
    • (2003) Nat Med , vol.9 , Issue.4 , pp. 407-415
    • Qi, J.H.1    Ebrahem, Q.2    Moore, N.3    Murphy, G.4    Claesson-Welsh, L.5    Bond, M.6    Baker, A.7    Anand-Apte, B.8
  • 167
    • 69249127912 scopus 로고    scopus 로고
    • Zebularine-induced reduction in VEGF secretion by HIF-1α degradation in oral squamous cell carcinoma
    • COI: 1:CAS:528:DC%2BD1cXotlyrs74%3D
    • Suzuki M, Shinohara F, Rikiishi H (2008) Zebularine-induced reduction in VEGF secretion by HIF-1α degradation in oral squamous cell carcinoma. Mol Med Rep 1(4):465–471
    • (2008) Mol Med Rep , vol.1 , Issue.4 , pp. 465-471
    • Suzuki, M.1    Shinohara, F.2    Rikiishi, H.3
  • 168
    • 65349111237 scopus 로고    scopus 로고
    • Synergistic effect of trichostatin A and 5-aza-2′-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study
    • COI: 1:CAS:528:DC%2BD1MXltVertrc%3D
    • Cecconi D, Donadelli M, Pozza ED, Rinalducci S, Zolla L, Scupoli MT, Righetti PG, Scarpa A, Palmieri M (2009) Synergistic effect of trichostatin A and 5-aza-2′-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. Proteomics 9(7):1952–1966
    • (2009) Proteomics , vol.9 , Issue.7 , pp. 1952-1966
    • Cecconi, D.1    Donadelli, M.2    Pozza, E.D.3    Rinalducci, S.4    Zolla, L.5    Scupoli, M.T.6    Righetti, P.G.7    Scarpa, A.8    Palmieri, M.9
  • 169
    • 0037400558 scopus 로고    scopus 로고
    • Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells
    • COI: 1:CAS:528:DC%2BD3sXhs1Khtrg%3D
    • Shaker S, Bernstein M, Momparler LF, Momparler RL (2003) Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells. Leuk Res 27(5):437–444
    • (2003) Leuk Res , vol.27 , Issue.5 , pp. 437-444
    • Shaker, S.1    Bernstein, M.2    Momparler, L.F.3    Momparler, R.L.4
  • 170
    • 37549022694 scopus 로고    scopus 로고
    • DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes
    • COI: 1:CAS:528:DC%2BD1cXhvFGhsrk%3D
    • Griffiths EA, Gore SD (2008) DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes. Semin Hematol 45(1):23–30
    • (2008) Semin Hematol , vol.45 , Issue.1 , pp. 23-30
    • Griffiths, E.A.1    Gore, S.D.2
  • 171
    • 84907689730 scopus 로고    scopus 로고
    • A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study
    • COI: 1:CAS:528:DC%2BC2cXhs1ymt7rN
    • Kirschbaum MH, Foon KA, Frankel P, Ruel C, Pulone B, Tuscano JM, Newman EM (2014) A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study. Leuk Lymphoma 55(10):2301–2304
    • (2014) Leuk Lymphoma , vol.55 , Issue.10 , pp. 2301-2304
    • Kirschbaum, M.H.1    Foon, K.A.2    Frankel, P.3    Ruel, C.4    Pulone, B.5    Tuscano, J.M.6    Newman, E.M.7
  • 172
    • 33745714230 scopus 로고    scopus 로고
    • Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms
    • COI: 1:CAS:528:DC%2BD28XlvVSkurc%3D
    • Gore SD et al (2006) Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. Cancer Res 66(12):6361–6369
    • (2006) Cancer Res , vol.66 , Issue.12 , pp. 6361-6369
    • Gore, S.D.1
  • 173
    • 68049120458 scopus 로고    scopus 로고
    • Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes
    • COI: 1:CAS:528:DC%2BD1MXptl2gtrg%3D
    • Voso MT et al (2009) Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. Clin Cancer Res 15(15):5002–5007
    • (2009) Clin Cancer Res , vol.15 , Issue.15 , pp. 5002-5007
    • Voso, M.T.1
  • 174
    • 70350506791 scopus 로고    scopus 로고
    • Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies
    • COI: 1:CAS:528:DC%2BD1MXht1eit7jL
    • Fandy TE et al (2009) Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies. Blood 114(13):2764–2773
    • (2009) Blood , vol.114 , Issue.13 , pp. 2764-2773
    • Fandy, T.E.1
  • 175
    • 84858685501 scopus 로고    scopus 로고
    • Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
    • COI: 1:CAS:528:DC%2BC38XktVajsL8%3D
    • Gryder BE, Sodji QH, Oyelere Adegboyega K (2012) Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed. Futur Med Chem 4(4):505–524
    • (2012) Futur Med Chem , vol.4 , Issue.4 , pp. 505-524
    • Gryder, B.E.1    Sodji, Q.H.2    Oyelere Adegboyega, K.3
  • 176
    • 34547653955 scopus 로고    scopus 로고
    • Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma
    • COI: 1:CAS:528:DC%2BD2sXotlGqurc%3D
    • Kato Y, Yoshimura K, Shin T, Verheul H, Hammers H, Sanni TB, Salumbides BC, Van Erp K, Schulick R, Pili R (2007) Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma. Clin Cancer Res 13(15):4538–4546
    • (2007) Clin Cancer Res , vol.13 , Issue.15 , pp. 4538-4546
    • Kato, Y.1    Yoshimura, K.2    Shin, T.3    Verheul, H.4    Hammers, H.5    Sanni, T.B.6    Salumbides, B.C.7    Van Erp, K.8    Schulick, R.9    Pili, R.10
  • 177
    • 84856403025 scopus 로고    scopus 로고
    • Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models
    • COI: 1:CAS:528:DC%2BC38Xitlyqs7c%3D
    • Shen L, Ciesielski M, Ramakrishnan S, Miles KM, Ellis L, Sotomayor P, Shrikant P, Fenstermaker R, Pili R (2012) Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models. PLoS ONE 7(1):e30815
    • (2012) PLoS ONE , vol.7 , Issue.1
    • Shen, L.1    Ciesielski, M.2    Ramakrishnan, S.3    Miles, K.M.4    Ellis, L.5    Sotomayor, P.6    Shrikant, P.7    Fenstermaker, R.8    Pili, R.9
  • 178
    • 84855340600 scopus 로고    scopus 로고
    • Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours
    • COI: 1:CAS:528:DC%2BC38XktFCnsQ%3D%3D
    • Pili R, Salumbides B, Zhao M, Altiok S, Qian D, Zwiebel J, Carducci MA, Rudek MA (2012) Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours. Br J Cancer 106(1):77–84
    • (2012) Br J Cancer , vol.106 , Issue.1 , pp. 77-84
    • Pili, R.1    Salumbides, B.2    Zhao, M.3    Altiok, S.4    Qian, D.5    Zwiebel, J.6    Carducci, M.A.7    Rudek, M.A.8
  • 180
    • 84940109072 scopus 로고    scopus 로고
    • Targeting epigenetic processes in photodynamic therapy-induced anticancer immunity
    • Wachowska M, Muchowicz A, Golab J (2015) Targeting epigenetic processes in photodynamic therapy-induced anticancer immunity. Front Oncol 5:176
    • (2015) Front Oncol , vol.5 , pp. 176
    • Wachowska, M.1    Muchowicz, A.2    Golab, J.3
  • 181
    • 84921963991 scopus 로고    scopus 로고
    • Broad targeting of angiogenesis for cancer prevention and therapy
    • Wang Z et al (2015) Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol 35(Suppl):S224–S243
    • (2015) Semin Cancer Biol , vol.35 , pp. S224-S243
    • Wang, Z.1
  • 182
    • 85017413453 scopus 로고    scopus 로고
    • Antiangiogenic therapy combined with immune checkpoint blockade in renal cancer: a review
    • Kuusk T, Grivas N, Bex A (2017) Antiangiogenic therapy combined with immune checkpoint blockade in renal cancer: a review. Angiogenesis. doi:10.1007/s10456-017-9550-0
    • (2017) Angiogenesis
    • Kuusk, T.1    Grivas, N.2    Bex, A.3
  • 183
    • 85016580058 scopus 로고    scopus 로고
    • Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? Angiogenesis
    • Ramjiawan RR, Griffioen AW, Duda DG (2017) Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? Angiogenesis. doi:10.1007/s10456-017-9552-y
    • (2017) Duda DG
    • Ramjiawan, R.R.1    Griffioen, A.W.2
  • 184
    • 85016484861 scopus 로고    scopus 로고
    • The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future
    • Hamming LC, Slotman BJ, Verheul HMW, Thijssen V (2017) The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future. Angiogenesis. doi:10.1007/s10456-017-9546-9
    • (2017) Angiogenesis
    • Hamming, L.C.1    Slotman, B.J.2    Verheul, H.M.W.3    Thijssen, V.4
  • 185
    • 0028060380 scopus 로고
    • Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
    • COI: 1:CAS:528:DyaK2cXmtVajtLk%3D
    • Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265(5178):1582–1584
    • (1994) Science , vol.265 , Issue.5178 , pp. 1582-1584
    • Dameron, K.M.1    Volpert, O.V.2    Tainsky, M.A.3    Bouck, N.4
  • 187
    • 80155142474 scopus 로고    scopus 로고
    • Rapamycin passes the torch: a new generation of mTOR inhibitors
    • COI: 1:CAS:528:DC%2BC3MXhtlyis7vI
    • Benjamin D, Colombi M, Moroni C, Hall MN (2011) Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat Rev Drug Discov 10(11):868–880
    • (2011) Nat Rev Drug Discov , vol.10 , Issue.11 , pp. 868-880
    • Benjamin, D.1    Colombi, M.2    Moroni, C.3    Hall, M.N.4
  • 191
    • 67349157687 scopus 로고    scopus 로고
    • Biomarkers for predicting clinical responses to HDAC inhibitors
    • COI: 1:CAS:528:DC%2BD1MXmsF2jt7o%3D
    • Stimson L, La Thangue NB (2009) Biomarkers for predicting clinical responses to HDAC inhibitors. Cancer Lett 280(2):177–183
    • (2009) Cancer Lett , vol.280 , Issue.2 , pp. 177-183
    • Stimson, L.1    La Thangue, N.B.2
  • 193
    • 0034326784 scopus 로고    scopus 로고
    • Reversal of drug resistance in human tumor xenografts by 2′-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter
    • COI: 1:CAS:528:DC%2BD3cXotV2lsL8%3D
    • Plumb JA, Strathdee G, Sludden J, Kaye SB, Brown R (2000) Reversal of drug resistance in human tumor xenografts by 2′-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. Cancer Res 60(21):6039–6044
    • (2000) Cancer Res , vol.60 , Issue.21 , pp. 6039-6044
    • Plumb, J.A.1    Strathdee, G.2    Sludden, J.3    Kaye, S.B.4    Brown, R.5
  • 194
    • 85006437080 scopus 로고    scopus 로고
    • Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms
    • Wang L, Li H, Ren Y, Zou S, Fang W, Jiang X, Jia L, Li M, Liu X, Yuan X, Chen G, Yang J, Wu C (2016) Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms. Cell Death Dis. doi:10.1038/cddis.2015.328
    • (2016) Cell Death Dis
    • Wang, L.1    Li, H.2    Ren, Y.3    Zou, S.4    Fang, W.5    Jiang, X.6    Jia, L.7    Li, M.8    Liu, X.9    Yuan, X.10    Chen, G.11    Yang, J.12    Wu, C.13
  • 196
    • 33947242973 scopus 로고    scopus 로고
    • Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation
    • COI: 1:CAS:528:DC%2BD2sXhvF2hsLg%3D
    • Yu C, Friday BB, Lai J-P, McCollum A, Atadja P, Roberts LR, Adjei AA (2007) Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation. Clin Cancer Res 13(4):1140–1148
    • (2007) Clin Cancer Res , vol.13 , Issue.4 , pp. 1140-1148
    • Yu, C.1    Friday, B.B.2    Lai, J.-P.3    McCollum, A.4    Atadja, P.5    Roberts, L.R.6    Adjei, A.A.7
  • 199
    • 3242885067 scopus 로고    scopus 로고
    • Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo
    • COI: 1:CAS:528:DC%2BD2cXlvFehtLw%3D
    • Peinado H, Marin F, Cubillo E, Stark H-J, Fusenig N, Nieto MA, Cano A (2004) Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo. J Cell Sci 117(Pt 13):2827–2839
    • (2004) J Cell Sci , vol.117 , pp. 2827-2839
    • Peinado, H.1    Marin, F.2    Cubillo, E.3    Stark, H.-J.4    Fusenig, N.5    Nieto, M.A.6    Cano, A.7
  • 200
    • 84884995769 scopus 로고    scopus 로고
    • The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells
    • COI: 1:CAS:528:DC%2BC3sXhsV2mtb7J
    • Chen M-C, Chen C-H, Wang J-C, Tsai A-C, Liou J-P, Pan S-L, Teng C-M (2013) The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells. Cell Death Dis 4:e810
    • (2013) Cell Death Dis , vol.4
    • Chen, M.-C.1    Chen, C.-H.2    Wang, J.-C.3    Tsai, A.-C.4    Liou, J.-P.5    Pan, S.-L.6    Teng, C.-M.7
  • 201
    • 84924875404 scopus 로고    scopus 로고
    • The combination of irreversible EGFR TKIs and SAHA induces apoptosis and autophagy-mediated cell death to overcome acquired resistance in EGFR T790M-mutated lung cancer
    • COI: 1:CAS:528:DC%2BC2cXhvF2jsLfF
    • Lee T-G, Jeong E-H, Kim SY, Kim H-R, Kim CH (2015) The combination of irreversible EGFR TKIs and SAHA induces apoptosis and autophagy-mediated cell death to overcome acquired resistance in EGFR T790M-mutated lung cancer. Int J Cancer 136(11):2717–2729
    • (2015) Int J Cancer , vol.136 , Issue.11 , pp. 2717-2729
    • Lee, T.-G.1    Jeong, E.-H.2    Kim, S.Y.3    Kim, H.-R.4    Kim, C.H.5
  • 202
    • 84864004796 scopus 로고    scopus 로고
    • Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy
    • COI: 1:CAS:528:DC%2BC38XhtFCjtrbO
    • Witta SE, Jotte RM, Konduri K, Neubauer MA, Spira AI, Ruxer RL, Varella-Garcia M, Bunn PA, Hirsch FR (2012) Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy. J Clin Oncol 30(18):2248–2255
    • (2012) J Clin Oncol , vol.30 , Issue.18 , pp. 2248-2255
    • Witta, S.E.1    Jotte, R.M.2    Konduri, K.3    Neubauer, M.A.4    Spira, A.I.5    Ruxer, R.L.6    Varella-Garcia, M.7    Bunn, P.A.8    Hirsch, F.R.9
  • 204
    • 77952673621 scopus 로고    scopus 로고
    • Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates
    • COI: 1:CAS:528:DC%2BC3cXhtV2ntrzN
    • Loges S, Schmidt T, Carmeliet P (2010) Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates. Genes Cancer 1(1):12–25
    • (2010) Genes Cancer , vol.1 , Issue.1 , pp. 12-25
    • Loges, S.1    Schmidt, T.2    Carmeliet, P.3
  • 205
    • 84921963991 scopus 로고    scopus 로고
    • Broad targeting of angiogenesis for cancer prevention and therapy
    • Wang Z et al (2015) Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol 35(Suppl):S224–S243
    • (2015) Semin Cancer Biol , vol.35 , pp. S224-S243
    • Wang, Z.1
  • 207
    • 84979058861 scopus 로고    scopus 로고
    • Manipulating angiogenesis by targeting endothelial metabolism: hitting the engine rather than the drivers—a new perspective?
    • Treps L, Conradi L-C, Harjes U, Carmeliet P (2016) Manipulating angiogenesis by targeting endothelial metabolism: hitting the engine rather than the drivers—a new perspective? Pharmacol Rev 68(3):872–887
    • (2016) Pharmacol Rev , vol.68 , Issue.3 , pp. 872-887
    • Treps, L.1    Conradi, L.-C.2    Harjes, U.3    Carmeliet, P.4
  • 209
    • 33847701595 scopus 로고    scopus 로고
    • Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma
    • COI: 1:CAS:528:DC%2BD2sXhvVWqtb8%3D
    • Yang Q, Tian Y, Liu S, Zeine R, Chlenski A, Salwen HR, Henkin J, Cohn SL (2007) Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma. Cancer Res 67(4):1716–1724
    • (2007) Cancer Res , vol.67 , Issue.4 , pp. 1716-1724
    • Yang, Q.1    Tian, Y.2    Liu, S.3    Zeine, R.4    Chlenski, A.5    Salwen, H.R.6    Henkin, J.7    Cohn, S.L.8
  • 210
    • 0035866341 scopus 로고    scopus 로고
    • Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis
    • COI: 1:CAS:528:DC%2BD3MXhvVeltLo%3D
    • Pili R, Kruszewski MP, Hager BW, Lantz J, Carducci MA (2001) Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis. Cancer Res 61(4):1477–1485
    • (2001) Cancer Res , vol.61 , Issue.4 , pp. 1477-1485
    • Pili, R.1    Kruszewski, M.P.2    Hager, B.W.3    Lantz, J.4    Carducci, M.A.5
  • 211
    • 77956652390 scopus 로고    scopus 로고
    • Resveratrol modulates angiogenesis through the GSK3β/β-catenin/TCF-dependent pathway in human endothelial cells
    • COI: 1:CAS:528:DC%2BC3cXhtFyitbjM
    • Wang H, Zhou H, Zou Y, Liu Q, Guo C, Gao G, Shao C, Gong Y (2010) Resveratrol modulates angiogenesis through the GSK3β/β-catenin/TCF-dependent pathway in human endothelial cells. Biochem Pharmacol 80(9):1386–1395
    • (2010) Biochem Pharmacol , vol.80 , Issue.9 , pp. 1386-1395
    • Wang, H.1    Zhou, H.2    Zou, Y.3    Liu, Q.4    Guo, C.5    Gao, G.6    Shao, C.7    Gong, Y.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.